Completed PHASE4 INTERVENTIONAL 2-arm NCT02647619

Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF

A Randomized Controlled Trial (RCT) Comparing Clostridium Histolyticum With Needle Aponeurotomy.

Sponsor: University Hospital, Akershus

Interventions Needle aponeurotomy Xiapex

Updated 9 times since 2017 Last updated: Apr 19, 2022 Started: Oct 31, 2013 Primary completion: Apr 30, 2022 Completion: Apr 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02647619, this PHASE4 trial focuses on Dupuytren Contracture and remains completed. Sponsored by University Hospital, Akershus, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
May 2022 — Jul 2024 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Feb 2021 — May 2022 [monthly]

Active Not Recruiting PHASE4
Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting PHASE4

▶ Show 4 earlier versions

Feb 2019 — Jan 2021 [monthly]

Active Not Recruiting PHASE4
Jun 2018 — Feb 2019 [monthly]

Active Not Recruiting PHASE4
Feb 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE4
Jan 2017 — Feb 2018 [monthly]

Active Not Recruiting PHASE4

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Akershus

Data source: University Hospital, Akershus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway